<code id='86BF6946A9'></code><style id='86BF6946A9'></style>
    • <acronym id='86BF6946A9'></acronym>
      <center id='86BF6946A9'><center id='86BF6946A9'><tfoot id='86BF6946A9'></tfoot></center><abbr id='86BF6946A9'><dir id='86BF6946A9'><tfoot id='86BF6946A9'></tfoot><noframes id='86BF6946A9'>

    • <optgroup id='86BF6946A9'><strike id='86BF6946A9'><sup id='86BF6946A9'></sup></strike><code id='86BF6946A9'></code></optgroup>
        1. <b id='86BF6946A9'><label id='86BF6946A9'><select id='86BF6946A9'><dt id='86BF6946A9'><span id='86BF6946A9'></span></dt></select></label></b><u id='86BF6946A9'></u>
          <i id='86BF6946A9'><strike id='86BF6946A9'><tt id='86BF6946A9'><pre id='86BF6946A9'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:12
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Baby aspirin cuts fat buildup in liver disease patients, in small study
          Baby aspirin cuts fat buildup in liver disease patients, in small study

          PatrickSison/APLow-doseaspirinledtoareductioninliverfatamongpatientswithmetabolic-associatedliverdis

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          AstraZeneca to buy developer of next

          AlastairGrant/APLONDON—AstraZenecasaidTuesdayitwouldacquireFusionPharmaceuticalsinadealworthmorethan